EU approves AstraZeneca/Pozen's Vimovo
This article was originally published in Scrip
Executive Summary
AstraZeneca/Pozen's arthritis drug Vimovo (naproxen and esomeprazole magnesium) now has regulatory approval in the EU, AstraZeneca has confirmed.